Fabrizio Nerozzi

Publications by Year

Research Areas

Neuroendocrine regulation and behavior, Health, Medicine and Society, Hermeneutics and Narrative Identity, Aging, Elder Care, and Social Issues, Organic and Inorganic Chemical Reactions

Most-Cited Works

• → The discovery of GSK221149A: A potent and selective oxytocin antagonist(2007)91 cited
• → Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency(2012)89 cited
• → 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR(2005)66 cited
• → 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics(2005)53 cited
• → Heterogeneous Catalytic Hydrogenation(2012)49 cited
• → 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency(2006)44 cited
• → Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives(2002)42 cited
• → [594] GSK625433; A NOVEL AND HIGHLY POTENT INHIBITOR OF THE HCV NS5B POLYMERASE(2007)21 cited
• Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.(2007)
• Preparation of 4-(methoxycarbonyl)pyrrolidine-2-carboxylic acid derivatives as hepatitis C virus inhibitors.(2006)